Browsing Centre for Clinical Pharmacology by Subject "India"
Now showing items 1-2 of 2
-
Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India.
(2018)Our previous research found seven specific factors that cause system delays in ST-elevation Myocardial infarction management in developing countries. These delays, in conjunction with a lack of organized STEMI systems of ... -
Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.
(2019-01)AIMS: Rising antimicrobial resistance (AMR) is a global health crisis. India has among the highest resistance rates and antibiotic consumption internationally. Extensive use of fixed-dose combination (FDC) antibiotics and ...